Jim Sullivan

Private Equity Investor chez OrbiMed Advisors Private Equity

Profil

Jim Sullivan, Ph.D., is a Venture Partner with OrbiMed.
Previously, Dr. Sullivan was the Vice President of Discovery at Abbvie, responsible for AbbVie’s research efforts in a variety of therapeutic/disease areas including oncology, immunology, neurology, hepatitis C and cystic fibrosis.
Jim has advanced more than 100 compounds into clinical development across a number of disease states and technology platforms.
He has authored/co-authored more than 130 scientific publications and is an inventor on 11 patents.
Jim is an adjunct faculty member at Northwestern University and serves on the board of a number of companies and foundations.
He earned his bachelor's degree and Ph.D.
in biochemistry from Trinity College in Dublin, Ireland, and conducted post-doctoral research in neurobiology at Northwestern University.

Postes actifs de Jim Sullivan

Sociétés	Poste	Début
OrbiMed Advisors Private Equity	Private Equity Investor	01/01/2019

Anciens postes connus de Jim Sullivan

Sociétés	Poste	Fin
ABBVIE INC.	Private Equity Investor	01/12/2018
ABBOTT LABORATORIES	Private Equity Investor	01/12/2012